BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16600362)

  • 1. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
    Li Y; Dong L; Jia A; Chang X; Xue H
    Int J Biol Macromol; 2006 May; 38(3-5):296-9. PubMed ID: 16600362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of tetrandrine solid lipid nanoparticles].
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):541-4. PubMed ID: 16762843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release].
    Chen YJ; Jin RX; Zhou YQ; Zeng J; Zhang H; Feng QR
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):376-9. PubMed ID: 16711418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD; Tang X; Cui FD
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
    Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
    Souto EB; Anselmi C; Centini M; Müller RH
    Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles.
    Ruktanonchai U; Sakulkhu U; Bejrapha P; Opanasopit P; Bunyapraphatsara N; Junyaprasert V; Puttipipatkhachorn S
    J Microencapsul; 2009 Nov; 26(7):614-26. PubMed ID: 19839797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.